Shedding of SARS-CoV-2 after Immunosuppression The prolonged contagious period after
viral infection in immunocompromised patients may affect how long precautions will be …

Methods| On presentation for outpatient or inpatient care, patients were screened for the
presence of symptoms of COVID-19 or exposure to contacts with known SARS-CoV-2 infection. …

Acquired somatic mutations in hematopoietic stem and progenitor cells (clonal hematopoiesis
or CH) are associated with advanced age, increased risk of cardiovascular and malignant …

As of 10 April 2020, New York State had 180,458 cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and 9,385 reported deaths. Patients with cancer comprised …

BACKGROUND Understanding outcomes and immunologic characteristics of cellular therapy
recipients with SARS-CoV-2 is critical to performing these potentially life-saving therapies …

Nosocomial infections are those that become evident 48 h or more after a patient is
admitted for treatment in a hospital or in another health-care setting. These infections cause …

Bloodstream infection by highly antibiotic-resistant bacteria, such as vancomycin-resistant
Enterococcus (VRE), is a growing clinical problem that increasingly defies medical intervention…

Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …

Central nervous system (CNS) infections are potentially life threatening if not diagnosed
and treated early. The initial clinical presentations of many CNS infections are non-specific, …

Persistent COVID-19 infection is a unique concern in patients with hematologic malignancies.
While vaccination against severe acute respiratory syndrome coronavirus 2 has reduced …